Who owns REGENERON PHARMACEUTICALS, INC. (REGN)? Elite investor 13F holders
11 tracked elite investors reported holding REGENERON PHARMACEUTICALS, INC as of 2026-06-30, including Dodge & Cox Funds, Sound Shore, Southeastern Asset Management, Renaissance Technologies LLC, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
11 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Dodge & Cox Funds | REGENERON PHARMACEUTICALS | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 3037348765.00 USD | 4871137.000000 | Shares | add | Original filing |
| Sound Shore | REGENERON PHARMACEUTICALS | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 79185839.00 USD | 126994.000000 | Shares | reduce | Original filing |
| Southeastern Asset Management | REGENERON PHARMACEUTICALS | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 94978860.00 USD | 152322.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | REGENERON PHARMACEUTICALS | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 92422346.00 USD | 148222.000000 | Shares | add | Original filing |
| Gotham Asset Management | REGENERON PHARMACEUTICALS | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 65574584.00 USD | 105165.000000 | Shares | add | Original filing |
| GMO | REGENERON PHARMACEUTICALS | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 46266668.00 USD | 74200.000000 | Shares | add | Original filing |
| Bridgewater Associates | REGENERON PHARMACEUTICALS | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 32008179.00 USD | 51333.000000 | Shares | add | Original filing |
| D.E. Shaw | REGENERON PHARMACEUTICALS | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 23991948.00 USD | 38477.000000 | Shares | add | Original filing |
| Sarissa Capital | REGENERON PHARMACEUTICALS | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2612633.00 USD | 4190.000000 | Shares | hold | Original filing |
| GAMCO | REGENERON PHARMACEUTICALS | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 409666.00 USD | 657.000000 | Shares | add | Original filing |
| Ancora Advisors / Ancora Holdings | REGENERON PHARMACEUTICALS | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 39283.00 USD | 63.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.